JournalsHub
.online
Find My Journal
YZ

Yuting Zuo

IDEX Corporation (United States) US

4
Publications
236
Citations
3
H-Index
3
i10-Index
0
2yr Mean Cite
True
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

4 total

Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.

Nai‐Kong V. Cheung, Shakeel Modak, Yukang Lin, Hong-Fen Guo, Pat Zanzonico et al. - PubMed, 2004
Cited by 56 OpenAlex

Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.

Scott S. Graves, Erica Dearstyne, Yukang Lin, Yuting Zuo, James Sanderson et al. - PubMed, 2003
Cited by 53 OpenAlex

A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

Jody Schultz, Yukang Lin, James Sanderson, Yuting Zuo, Diane Stone et al. - PubMed, 2000
Cited by 127 OpenAlex

Research Topics

Radiopharmaceutical Chemistry and Applications (3) HER2/EGFR in Cancer Research (2) Monoclonal and Polyclonal Antibodies Research (2) Pancreatic and Hepatic Oncology Research (1) Radiation Therapy and Dosimetry (1)

Affiliations

Nexen (Canada)
CA 2003 - 2003
IDEX Corporation (United States)
US 2004 - 2004

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now